Deletion of Brg1 during pancreatic development in conjunction with oncogenic Kras results in the formation of IPMN-like lesions contiguous with the native duct system that may derive from the ductal compartment rather than through ADM. The gene discussed is KRAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.